- Book
- April 2018
- 320 Pages
- Book
- January 2008
- 460 Pages
- Book
- November 2024
- 848 Pages
- Book
- October 2022
- 400 Pages
- Book
- September 2022
- 208 Pages
- Book
- March 2022
- 896 Pages
- Book
- September 2021
- 432 Pages
- Book
- February 2021
- 544 Pages
- Book
- December 2020
- 300 Pages
- Book
- September 2020
- 528 Pages
- Book
- September 2020
- 1136 Pages
- Book
- January 2020
- 424 Pages
- Book
- July 2019
- 352 Pages
- Book
- December 2018
- 416 Pages
- Book
- April 2018
- 432 Pages
- Book
- January 2018
- 176 Pages

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more